GEODE CAPITAL MANAGEMENT, LLC

Position in ACRS — Aclaris Therapeutics, Inc.

CIK 1214717 BOSTON, MA

Back to ACRS Full portfolio

Position in ACRS

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$9,088,840

+$1,886,597 QoQ

Shares Held

2,423,691

+1.3% QoQ

Ownership

1.74%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2020

25 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Common Shares in ACRS Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Mar 31, 2026

GEODE CAPITAL MANAGEMENT, LLC holds $18,583,356,554 across 528 Biotechnology names. ACRS ranks #172 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	6,139,621	$2,741,586,360
2	REGN	Regeneron Pharmaceuticals, Inc.	2,607,732	$2,014,838,051
3	ALNY	Alnylam Pharmaceuticals, Inc.	2,660,385	$880,241,584
4	INSM	INSMED Inc	4,450,389	$727,727,608
5	MRNA	Moderna, Inc.	9,435,132	$479,304,705
6	INCY	Incyte Corp	4,703,184	$442,663,677
7	RPRX	Royalty Pharma plc	7,869,632	$377,506,246
8	BBIO	BridgeBio Pharma, Inc.	4,918,030	$365,212,906

All Filings in ACRS

Export CSV

25 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$9,088,840	2,423,691	+1.3%	Shares	Defined	2026-05-15
2025-12-31	$7,202,243	2,392,772	+0.1%	Shares	Defined	2026-02-09
2025-09-30	$4,540,108	2,389,531	-3.1%	Shares	Defined	2025-11-12
2025-06-30	$3,499,985	2,464,779	+108.4%	Shares	Defined	2025-08-08
2025-03-31	$1,809,586	1,182,737	+49.8%	Shares	Defined	2025-05-13
2024-12-31	$1,958,199	789,597	-6.7%	Shares	Defined	2025-02-12
2024-09-30	$973,412	846,446	+9.3%	Shares	Defined	2024-11-12
2024-06-30	$851,549	774,137	-50.5%	Shares	Defined	2024-08-09
2024-03-31	$1,940,666	1,565,054	+12.3%	Shares	Defined	2024-05-13
2023-12-31	$1,463,225	1,393,548	+4.2%	Shares	Defined	2024-02-13
2023-09-30	$9,159,011	1,337,082	+8.1%	Shares	Defined	2023-11-13
2023-06-30	$12,831,931	1,237,409	+11.0%	Shares	Defined	2023-08-11
2023-03-31	$9,016,887	1,114,572	+5.3%	Shares	Defined	2023-05-15
2022-12-31	$16,675,281	1,058,748	+2.9%	Shares	Defined	2023-02-13
2022-09-30	$16,192,100	1,028,723	+7.5%	Shares	Defined	2022-11-14
2022-06-30	$13,362,735	957,216	+13.1%	Shares	Defined	2022-08-12
2022-03-31	$14,591,780	846,391	+4.7%	Shares	Defined	2022-05-13
2021-12-31	$11,755,037	808,462	+1.6%	Shares	Defined	2022-02-11
2021-09-30	$14,324,868	795,826	+10.7%	Shares	Defined	2021-11-12
2021-06-30	$12,621,372	718,757	+90.7%	Shares	Defined	2021-08-13
2021-03-31	$9,496,972	376,864	+16.0%	Shares	Defined	2021-05-12
2020-12-31	$2,102,593	324,976	-19.2%	Shares	Defined	2021-02-12
2020-09-30	$1,033,325	402,072	-2.5%	Shares	Defined	2020-11-13
2020-06-30	$668,371	412,575	-29.7%	Shares	Defined	2020-08-13
2020-03-31	$610,577	587,094	—	Shares	Defined	2020-05-14
No filing history on record for this holder in this stock.